China is making significant strides in oncology research. Data from the IQVIA Global Oncology Trends 2025 report highlights China’s growing role in clinical trials and novel cancer drugs. Therefore, this video companion explores these developments in detail. In addition, watch our exclusive video on OncologyTube.com for more insights!
Why China Matters in Oncology
China’s oncology trials have increased from 5% in 2009 to 39% in 2024. This growth exceeds other nations. Moreover, the country’s focus on advanced therapies supports this trend. As a result, let’s examine the data closely.
Key Highlights from the IQVIA Report
Surge in Clinical Trials
China now leads in global oncology trials. In 2024, it accounted for 39% of new starts. This is up from 5% a decade ago. Furthermore, the IQVIA report documents this shift effectively. Subsequently, read the full IQVIA report here.
- Trial Growth: A 34% increase since 2019.
- Focus Areas: Rare cancers and solid tumors make up 41% of trials.
Novel Cancer Drugs
China launched 25 new active substances (NAS) in 2023 alone. Over five years, this totals 132 NAS. Moreover, over 20 years, China has introduced 193 NAS. This surpasses the U.S. since 2019. Therefore, the report highlights China’s progress in drug development.
- Cilta-cel Breakthrough: China developed this CAR-T therapy. It offers a 34.9-month progression-free survival. Learn more from NEJM.
- Novel Modalities: 35% of trials involve ADCs and gene therapies.
Economic Impact
Global cancer spending reached $223 billion in 2023. It is projected to hit $409 billion by 2028. Meanwhile, China contributes to this growth significantly. Its flexible regulations speed up approvals. As a result, this supports innovation and spending.
What This Means for the Future
China’s leadership in oncology trials may influence global healthcare. Faster approvals and new therapies could benefit patients. Meanwhile, the U.S. faces funding challenges. Furthermore, Trump administration cuts to NIH grants since January 2025 may affect progress.
Conclusion
China’s rise in oncology trials is notable. It leads in trials, drugs, and innovation. Therefore, stay updated with our resources. Moreover, explore more cancer topics on OncologyTube.com.
Call to Action
- Share this post with others.
- Subscribe to our channel for updates.
- Visit OncologyTube.com for more insights.
SOURCE: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025
Related Links: